Journey Medical Corp expected to post a loss of 47 cents a share - Earnings Preview

Journey Medical

27/03/2023 21:45

* Journey Medical Corp  DERM.OQ   DERM.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 29. 
    * The Scottsdale Arizona-based  company is expected to
report  a
5.3% decrease in revenue to $16.58 million from $17.52 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Journey Medical
Corp is
for a loss of 47 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Journey
Medical
Corp is $6​, above​ its last closing price of $1.33. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.50       -0.40      -0.57     Missed  -43.7
 Jun. 30 2022  -0.26       -0.26      -0.43     Missed  -67.5
 Mar. 31 2022  -0.31       -0.31      -0.08     Beat    74.2​
 Dec. 31 2021  -0.45       -0.41      -1.64     Missed  -296.8
 ​​                                                     
                                                        ​
 This summary was machine generated March 27 at 20:45 GMT.  All
figures in US dollars  unless otherwise stated